MX6242E - Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas - Google Patents

Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas

Info

Publication number
MX6242E
MX6242E MX798313U MX831379U MX6242E MX 6242 E MX6242 E MX 6242E MX 798313 U MX798313 U MX 798313U MX 831379 U MX831379 U MX 831379U MX 6242 E MX6242 E MX 6242E
Authority
MX
Mexico
Prior art keywords
tetrahidroimidazotienopirimidin
onas
procedure
preparation
Prior art date
Application number
MX798313U
Other languages
English (en)
Inventor
Fumiyoshi Ishikawa
Shinichiro Ashida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of MX6242E publication Critical patent/MX6242E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX798313U 1978-08-11 1979-08-10 Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas MX6242E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9783278A JPS5527105A (en) 1978-08-11 1978-08-11 Imidazothienopyrimidinones compound

Publications (1)

Publication Number Publication Date
MX6242E true MX6242E (es) 1985-01-28

Family

ID=14202683

Family Applications (1)

Application Number Title Priority Date Filing Date
MX798313U MX6242E (es) 1978-08-11 1979-08-10 Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas

Country Status (16)

Country Link
US (1) US4284773A (es)
EP (1) EP0008408B1 (es)
JP (1) JPS5527105A (es)
AU (1) AU529068B2 (es)
CA (1) CA1116597A (es)
CS (1) CS219256B2 (es)
DE (1) DE2961552D1 (es)
DK (1) DK153844C (es)
ES (1) ES483289A1 (es)
GR (1) GR73839B (es)
IL (1) IL57923A (es)
MX (1) MX6242E (es)
PH (1) PH15530A (es)
SU (1) SU880252A3 (es)
YU (1) YU41170B (es)
ZA (1) ZA793909B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287340A (en) * 1979-08-27 1981-09-01 Warner-Lambert Company Dihydro-oxo-pyrido[1,2-a]thienopyrimidine compounds
ZW11781A1 (en) * 1980-06-27 1982-01-20 Hoffmann La Roche Pyrimidine derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890321A (en) * 1971-09-20 1975-06-17 Pfizer 6-aryl-5-ethyl-pyrimidin-4-ol compounds useful as intermediates and bronchodilators
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
DE2411273A1 (de) * 1974-03-06 1975-09-18 Schering Ag Neue thieno eckige klammer auf 2,3-d eckige klammer zu pyrimidinone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL57923A (en) 1982-09-30
EP0008408A1 (en) 1980-03-05
JPS627914B2 (es) 1987-02-19
DK153844B (da) 1988-09-12
AU4973579A (en) 1980-02-14
IL57923A0 (en) 1979-11-30
US4284773A (en) 1981-08-18
JPS5527105A (en) 1980-02-27
DK153844C (da) 1989-01-30
YU41170B (en) 1986-12-31
ZA793909B (en) 1980-10-29
DK336779A (da) 1980-02-12
ES483289A1 (es) 1980-09-01
YU194779A (en) 1983-10-31
EP0008408B1 (en) 1981-12-09
SU880252A3 (ru) 1981-11-07
CA1116597A (en) 1982-01-19
DE2961552D1 (en) 1982-02-04
PH15530A (en) 1983-02-09
GR73839B (es) 1984-05-04
AU529068B2 (en) 1983-05-26
CS219256B2 (en) 1983-03-25

Similar Documents

Publication Publication Date Title
MX6046E (es) Procedimiento para la preparacion de 4,5-diaril-2-nitro-imidazoles
MX5631E (es) Procedimiento para la preparacion de acil-anilinas
MX7623E (es) Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas
ES481909A0 (es) Procedimiento para la preparacion de nuevas aril-3 eter-5 o-xazolidinonas-2
ES482499A0 (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
MX6242E (es) Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
MX5509E (es) Procedimiento para la preparacion de n-halogenoacetil-fenilaminocarboniloximas
ES496019A0 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
MX5898E (es) Procedimiento para la preparacion de 2-amino-4-pirimidonas
ES491683A0 (es) Procedimiento para la preparacion de 1,3,7-trialquilxantinas
MX5685E (es) Procedimiento para la preparacion de 4,5-diaril-2-(tio-substituido)-pirrol
AR220383A1 (es) Procedimiento para la preparacion de 2,3,5,6-tetracloropiridina y pentacloropiridina
ES485567A0 (es) Procedimiento para la preparacion de azolilcetales
MX6217E (es) Procedimiento para la preparacion de 4,1-benzoxazepinas y 4,1-benzotiazepinas
MX5443E (es) Procedimiento para la preparacion de derivados de 1,1-difeniletano
MX5909E (es) Procedimiento mejorado para la preparacion de ciclohexanona
MX149694A (es) Procedimiento para la preparacion de trialcoxisilanos de fenoxialquilo
ES484342A0 (es) Procedimiento para la preparacion de propenilensulfona
MX5508E (es) Procedimiento para la preparacion de o-carbamoiloximas de 2,3-dihidro-4h-1-benzopiran-4-ona
MX5605E (es) Procedimiento mejorado para la preparacion de 2-isopropilaminopirimidina
MX4991E (es) Procedimiento para la preparacion de 2,4,diamino-5-tiobencilpirimidinas
ES490854A0 (es) Procedimiento para la preparacion de nuevas 1,3-benzoditiol-2-ona
ES490198A0 (es) Procedimiento mejorado para la preparacion de sulfonilureas
TR20895A (tr) 1,2,3-tiyadiyazol-5-yl uerelerinin hazirlanmasina mahsus usul